Brain structural correlates of insomnia severity in 1053 individuals with major depressive disorder: results from the ENIGMA MDD Working Group.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
08 12 2020
Historique:
received: 08 04 2020
accepted: 17 11 2020
revised: 04 11 2020
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 22 6 2021
Statut: epublish

Résumé

It has been difficult to find robust brain structural correlates of the overall severity of major depressive disorder (MDD). We hypothesized that specific symptoms may better reveal correlates and investigated this for the severity of insomnia, both a key symptom and a modifiable major risk factor of MDD. Cortical thickness, surface area and subcortical volumes were assessed from T1-weighted brain magnetic resonance imaging (MRI) scans of 1053 MDD patients (age range 13-79 years) from 15 cohorts within the ENIGMA MDD Working Group. Insomnia severity was measured by summing the insomnia items of the Hamilton Depression Rating Scale (HDRS). Symptom specificity was evaluated with correlates of overall depression severity. Disease specificity was evaluated in two independent samples comprising 2108 healthy controls, and in 260 clinical controls with bipolar disorder. Results showed that MDD patients with more severe insomnia had a smaller cortical surface area, mostly driven by the right insula, left inferior frontal gyrus pars triangularis, left frontal pole, right superior parietal cortex, right medial orbitofrontal cortex, and right supramarginal gyrus. Associations were specific for insomnia severity, and were not found for overall depression severity. Associations were also specific to MDD; healthy controls and clinical controls showed differential insomnia severity association profiles. The findings indicate that MDD patients with more severe insomnia show smaller surfaces in several frontoparietal cortical areas. While explained variance remains small, symptom-specific associations could bring us closer to clues on underlying biological phenomena of MDD.

Identifiants

pubmed: 33293520
doi: 10.1038/s41398-020-01109-5
pii: 10.1038/s41398-020-01109-5
pmc: PMC7723989
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

425

Subventions

Organisme : Medical Research Council
ID : MC_PC_17209
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : T32 AG058507
Pays : United States

Références

Neurology. 2014 Sep 9;83(11):967-73
pubmed: 25186857
Psychosom Med. 2000 Jul-Aug;62(4):474-82
pubmed: 10949091
Brain Imaging Behav. 2019 Oct;13(5):1193-1201
pubmed: 30091019
Neuroimage. 2010 May 1;50(4):1497-510
pubmed: 20083210
BMC Med. 2013 May 14;11:126
pubmed: 23672542
JAMA Neurol. 2017 Jul 1;74(7):813-820
pubmed: 28558094
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Sci Rep. 2017 Aug 30;7(1):10095
pubmed: 28855654
Neurobiol Learn Mem. 2019 Apr;160:144-150
pubmed: 29448003
Brain Struct Funct. 2010 Jun;214(5-6):655-67
pubmed: 20512370
Comput Stat Data Anal. 2009 Jan 15;53(3):603-608
pubmed: 20084090
Nat Rev Neurosci. 2014 Mar;15(3):193-201
pubmed: 24518415
Nat Med. 2018 Dec;24(12):1910-1918
pubmed: 30374196
Biol Psychiatry. 2010 Jan 15;67(2):182-5
pubmed: 19782344
Sleep. 2016 Jan 01;39(1):161-71
pubmed: 26414892
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Am J Psychiatry. 2010 Jul;167(7):748-51
pubmed: 20595427
Nat Rev Neurosci. 2013 May;14(5):365-76
pubmed: 23571845
Science. 2020 Mar 20;367(6484):
pubmed: 32193296
Brain Imaging Behav. 2020 Oct;14(5):1309-1317
pubmed: 30511119
Sleep. 2016 Jan 01;39(1):227-35
pubmed: 26350471
Mol Psychiatry. 2017 Jun;22(6):900-909
pubmed: 27137745
PLoS One. 2018 Mar 6;13(3):e0193854
pubmed: 29509806
J Sleep Res. 2014 Jun;23(3):274-80
pubmed: 24456088
Arch Gen Psychiatry. 1992 Aug;49(8):651-68; discussion 669-70
pubmed: 1386215
Nat Genet. 2019 Mar;51(3):394-403
pubmed: 30804565
Lancet Psychiatry. 2019 Feb;6(2):151-163
pubmed: 30630691
Neuroimage. 2013 Oct 15;80:105-24
pubmed: 23668970
Neuroimage. 2013 Oct 15;80:62-79
pubmed: 23684880
Sleep Med Rev. 2017 Dec;36:71-81
pubmed: 29066053
Sleep. 2013 Jul 1;36(7):991-998
pubmed: 23814335
J Psychiatry Neurosci. 2018 Nov 01;43(6):366-374
pubmed: 30371992
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
J Clin Psychiatry. 2010 Mar;71(3):239-46
pubmed: 20331928
Sleep. 2017 Jan 01;40(1):
pubmed: 28364462
Sleep. 2019 Apr 1;42(4):
pubmed: 30590834
Neuroimage. 2010 Nov 15;53(3):1135-46
pubmed: 20006715
Front Aging Neurosci. 2016 Jan 19;7:250
pubmed: 26834623
Sleep. 2013 Aug 01;36(8):1153-62
pubmed: 23904675
Psychother Psychosom. 2019;88(1):52-54
pubmed: 30625483
Sleep. 2007 Aug;30(8):955-8
pubmed: 17702263
Mol Psychiatry. 2016 Jun;21(6):806-12
pubmed: 26122586
Brain Imaging Behav. 2018 Dec;12(6):1759-1767
pubmed: 29411240
Nat Genet. 2017 Nov;49(11):1584-1592
pubmed: 28604731
Nat Neurosci. 2000 Oct;3(10):1049-56
pubmed: 11017179
Sleep. 2016 Dec 01;39(12):2113-2124
pubmed: 27634787
Am J Psychiatry. 1997 Apr;154(4):502-9
pubmed: 9090337
Neuroimage. 2014 Feb 15;87:120-6
pubmed: 24246495
Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):2538-43
pubmed: 26858434
J Affect Disord. 2011 Dec;135(1-3):10-9
pubmed: 21300408
Brain Struct Funct. 2018 Sep;223(7):3411-3421
pubmed: 29948193
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
J Neurosci. 2014 Jun 18;34(25):8488-98
pubmed: 24948804
J Psychiatr Res. 2005 Sep;39(5):481-8
pubmed: 15992557
Hum Brain Mapp. 2015 Jul;36(7):2644-54
pubmed: 25832993
Front Psychiatry. 2018 Dec 04;9:651
pubmed: 30564152
Sleep. 2013 Jul 1;36(7):999-1007
pubmed: 23814336
Neurobiol Aging. 2018 Aug;68:76-84
pubmed: 29751288
J Psychosom Res. 2018 Mar;106:1-12
pubmed: 29455893
Sleep. 2014 Jul 01;37(7):1189-98
pubmed: 25061247
J Affect Disord. 2013 Apr 5;146(2):197-204
pubmed: 23021193

Auteurs

Jeanne Leerssen (J)

Department of Sleep and Cognition, Netherlands Institute for Neuroscience, an Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands. j.leerssen@vu.nl.
Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, The Netherlands. j.leerssen@vu.nl.

Tessa F Blanken (TF)

Department of Sleep and Cognition, Netherlands Institute for Neuroscience, an Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands.
Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, The Netherlands.

Elena Pozzi (E)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, VIC, Australia.
Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.

Neda Jahanshad (N)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Marina del Rey, CA, USA.

Lyubomir Aftanas (L)

Department of Clinical Neuroscience, Behavior & Neurotechnology, Scientific Research Institute of Neuroscience & Medicine, Novosibirsk, Russia.
Department of Neuroscience, Novosibirsk State University, Novosibirsk, Russia.

Ole A Andreassen (OA)

NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Bernhard T Baune (BT)

Department of Psychiatry, Melbourne Medical School, University of Melbourne, Parkville, VIC, Australia.
Department of Psychiatry, University of Münster, Münster, Germany.

Ivan Brack (I)

Department of Clinical Neuroscience, Behavior & Neurotechnology, Scientific Research Institute of Neuroscience & Medicine, Novosibirsk, Russia.

Angela Carballedo (A)

Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.

Christopher R K Ching (CRK)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Marina del Rey, CA, USA.

Udo Dannlowski (U)

Department of Psychiatry, University of Münster, Münster, Germany.

Katharina Dohm (K)

Department of Psychiatry, University of Münster, Münster, Germany.

Verena Enneking (V)

Department of Psychiatry, University of Münster, Münster, Germany.

Elena Filimonova (E)

Department of Clinical Neuroscience, Behavior & Neurotechnology, Scientific Research Institute of Neuroscience & Medicine, Novosibirsk, Russia.

Stella M Fingas (SM)

Department of Psychiatry, University of Münster, Münster, Germany.

Thomas Frodl (T)

Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.
Department of Psychiatry and Psychotherapy, Otto von Guericke University Magdeburg, Magdeburg, Germany.

Beata R Godlewska (BR)

Psychopharmacology Research Unit, Department of Psychiatry, University of Oxford, Oxford, UK.

Janik Goltermann (J)

Department of Psychiatry, University of Münster, Münster, Germany.

Ian H Gotlib (IH)

Department of Psychology, Stanford University, Stanford, CA, USA.

Dominik Grotegerd (D)

Department of Psychiatry, University of Münster, Münster, Germany.

Oliver Gruber (O)

Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany.

Mathew A Harris (MA)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Sean N Hatton (SN)

Youth Mental Health Team, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.

Emma Hawkins (E)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Ian B Hickie (IB)

Youth Mental Health Team, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.

Natalia Jaworska (N)

University of Ottawa's Institute of Mental Health Research, Ottawa, ON, Canada.
Cellular & Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.

Tilo Kircher (T)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.

Axel Krug (A)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.

Jim Lagopoulos (J)

Sunshine Coast Mind and Neuroscience Thompson Institute, Birtinya, QLD, Australia.

Hannah Lemke (H)

Department of Psychiatry, University of Münster, Münster, Germany.

Meng Li (M)

Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.
Max Planck Institute for Biological Cybernetics, Tübingen, Germany.

Frank P MacMaster (FP)

Psychiatry and Paediatrics, University of Calgary, Calgary, AB, Canada.
Strategic Clinical Network for Addictions and Mental Health, Calgary, AB, Canada.

Andrew M McIntosh (AM)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.
Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.

Quinn McLellan (Q)

Psychiatry and Paediatrics, University of Calgary, Calgary, AB, Canada.
Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.

Susanne Meinert (S)

Department of Psychiatry, University of Münster, Münster, Germany.

Benson Mwangi (B)

Department of Psychiatry, University of Texas Health Science Center at Houston, Houston, TX, USA.

Igor Nenadić (I)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.

Evgeny Osipov (E)

Department of Clinical Neuroscience, Behavior & Neurotechnology, Scientific Research Institute of Neuroscience & Medicine, Novosibirsk, Russia.

Maria J Portella (MJ)

Department of Psychiatry, Institute of Biomedical Research Sant Pau, Barcelona, Spain.
CIBERSAM, Barcelona, Spain.

Ronny Redlich (R)

Department of Psychiatry, University of Münster, Münster, Germany.
Department of Psychology, University of Halle, Halle, Germany.

Jonathan Repple (J)

Department of Psychiatry, University of Münster, Münster, Germany.

Matthew D Sacchet (MD)

Center for Depression, Anxiety, and Stress Research, McLean Hospital, Harvard Medical School, Belmont, MA, USA.

Philipp G Sämann (PG)

Max Planck Institute of Psychiatry, Munich, Germany.

Egle Simulionyte (E)

Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany.

Jair C Soares (JC)

UT Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.

Martin Walter (M)

Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.
Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.

Norio Watanabe (N)

Department of Health Promotion and Human Behavior, Graduate School of Public Health/ School of Public Health, Kyoto University, Kyoto, Japan.

Heather C Whalley (HC)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Dilara Yüksel (D)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
Center for Health Sciences, SRI International, Menlo Park, CA, USA.

Dick J Veltman (DJ)

Department of Psychiatry, Amsterdam UMC, Amsterdam Neuroscience, VU University, Amsterdam, Netherlands.
Amsterdam Neuroscience, VU University Medical Center, Amsterdam, Netherlands.

Paul M Thompson (PM)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Marina del Rey, CA, USA.

Lianne Schmaal (L)

Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia.

Eus J W Van Someren (EJW)

Department of Sleep and Cognition, Netherlands Institute for Neuroscience, an Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands.
Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, The Netherlands.
Department of Psychiatry, Amsterdam UMC, Amsterdam Neuroscience, VU University, Amsterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH